Jul 2, 2026 04:19AM
Jul 1, 2026 02:38PM
Jun 30, 2026 06:52AM
Jun 30, 2026 06:45AM
Jun 9, 2026 06:47AM
Jun 8, 2026 07:31AM
Jun 3, 2026 06:42AM Rodman & Renshaw Starts Neurogene (NGNE) at Buy, PT $70
May 12, 2026 05:28PM
Apr 28, 2026 06:10AM
Mar 26, 2026 06:48AM
Mar 24, 2026 10:50AM
Mar 24, 2026 10:28AM
Jan 26, 2026 07:50AM
Jan 12, 2026 07:57AM Stifel on Neurogene (NGNE): 'We continue to think that NGNE has a viable safety margin with the low dose'
Jan 12, 2026 07:00AM
Dec 17, 2025 05:28AM
Nov 14, 2025 07:26AM
Nov 13, 2025 09:45AM
Nov 13, 2025 06:44AM
Oct 9, 2025 07:01AM
Oct 3, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)
Aug 14, 2025 08:01AM
Aug 11, 2025 05:01PM
Jul 1, 2025 08:21AM
Jun 30, 2025 04:02PM
Jun 17, 2025 09:17AM
Jun 11, 2025 04:02PM
Jun 5, 2025 12:44PM FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
May 29, 2025 08:58AM
May 19, 2025 12:29PM
May 16, 2025 07:01AM
May 16, 2025 03:35AM
Apr 14, 2025 05:05AM
Apr 2, 2025 04:01PM
Mar 26, 2025 07:05AM Stifel Reiterates Buy Rating on Neurogene (NGNE)
Mar 24, 2025 04:38PM
Nov 25, 2024 06:47AM
Nov 20, 2024 04:54PM
Nov 19, 2024 04:02PM
Nov 19, 2024 11:07AM
Nov 19, 2024 03:50AM
Nov 18, 2024 06:45AM Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial
Nov 12, 2024 09:09AM
Nov 12, 2024 09:09AM
Nov 12, 2024 07:16AM
Nov 12, 2024 06:57AM
Nov 11, 2024 04:51PM
Nov 11, 2024 04:01PM
Nov 4, 2024 07:32AM Neurogene (NGNE) Announces Oversubscribed $200 Million Private Placement
Oct 16, 2024 07:53AM

428,392 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All